 |
FTI Consulting handles Abcam as the British biotechnology company agrees to a $5.7B takeover from DC-based Danaher Corp., which chalked up $31.5B in fiscal 2022 revenues.
Abcam will operate as a standalone company in Danaher’s life sciences division to bolster its strategy “to help map complex diseases and accelerate the drug discovery process."
Founded in Cambridge in 1998, Abcam’s validated antibodies, reagents, biomarkers and assays are used by an estimated 750K researchers.
Danaher CEO Rainer Blair said Abcam’s long track record of innovation and breadth of antibody portfolio positions makes it a key partner for the scientific community.
The transaction is expected to close mid-2024.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
